Cognition Therapeutics, Inc.

NASDAQ:CGTX

Biotechnology

Healthcare
$0.60 -0.70%

-$0.01 today

Market cap
$57.12M
Beta
1.75
P/E (TTM)
-6.4
EPS (TTM)
-$0.22
52W Low $0.25High $3.83

Volume 0.33M

Average 1.23M

Returns on capital

Cognition Therapeutics, Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-68.5%

avg -49.9%

ROIC

-136.9%

avg -226.3%

ROA

-48.5%

avg -69.6%

Analysis

ROA is currently the strongest return metric at -48.5% versus its period average of -69.6%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Lisa Ricciardi

Chief Executive Officer, President & DirectorUSD 1.06M661.72M2.33%

Anthony O. Caggiano

Chief Medical OfficerUSD 742.63K56——

John Brendan Doyle

Chief Financial OfficerUSD 681.53K49618.94K0.84%

Steven A. Weissman

Vice President & Head of CMC————

Bobby Horn

Corporate Controller————

Anita Cornet

Head of Quality————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding May 1, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

3

$32,492.50

Sells

0

$0.00

Net Transaction Value

+$32,492.50

Net buying

Most Active

Ricciardi Lisa

1 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Apr 16, 26

Ricciardi Lisa

Direct

Buy$10.1K
Apr 16, 26

Doyle John Brendan

Direct

Buy$11.3K
Apr 16, 26

Caggiano Anthony

Direct

Buy$11.1K

Summary

Insiders reported 3 buys worth $32,492.50 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $32,492.50. Ricciardi Lisa was the most active insider with 1 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/AN/A
N/A1 analysts
Net IncomeN/AN/AN/A
N/A1 analysts
EBITN/AN/AN/A
N/A1 analysts

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Competitors

Who does Cognition Therapeutics, Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about CGTX's management, answered from reported figures.

Who manages CGTX?

Cognition Therapeutics, Inc. (CGTX) lists 6 active executives. The top listed executive is Anthony O. Caggiano, Chief Medical Officer.

Are CGTX insiders buying or selling?

Recent insider activity shows net buying of $11.41M.